FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
ARK Hydrocodone Assay
K Number: K231752
·
Decision Nov 9, 2023
Classifications
1
FEI Numbers
100
Registration Numbers
100
Same Product Code
214
Applicant Total
17
Review Days
147
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- ARK Hydrocodone Assay
- K Number
- K231752
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.3650
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Ark Diagnostics, Inc.
- Date Received
- June 15, 2023
- Decision Date
- November 9, 2023
- Product Code
- DJG
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DJG | Enzyme Immunoassay, Opiates | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (DJG), ordered by most recent decision date.
Labcorp Fentanyl Urine Visual Test
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Evidence MultiSTAT DOA Urine MultiPlex
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LZI Buprenorphine II Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
SEFRIA Hydrocodone Oral Fluid
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative; Healgen® Immunofluorescence Analyzer (OG-H180)
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LZI Fentanyl III Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Ark Diagnostics, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K232522 | ARK Levetiracetam II Assay | Feb 27, 2024 | Substantially Equivalent |
| K232017 | ARK Methotrexate II Assay | Dec 20, 2023 | Substantially Equivalent |
| K201089 | ARK Lacosamide Assay | Aug 5, 2021 | Substantially Equivalent |
| K200197 | ARK Fentanyl II Assay | Feb 26, 2020 | Substantially Equivalent |
| K182280 | ARK Tramadol Assay | Dec 10, 2018 | Substantially Equivalent |
| K182779 | ARK EDDP Assay | Nov 21, 2018 | Substantially Equivalent |
| K180427 | ARK Fentanyl Assay | Jun 6, 2018 | Substantially Equivalent |
| K163359 | ARK Methotrexate Assay | Aug 18, 2017 | Substantially Equivalent |
| DEN160033 | ARK Voriconazole II Assay Test System | May 5, 2017 | Unknown |
| K153596 | ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK Oxcarbazepine Metabolite Control | Aug 9, 2016 | Substantially Equivalent |